July 2013
·
77 Reads
Journal of Krishna Institute of Medical Sciences University
Background: Laboratory help is must for the diagnosis of human brucellosis due to protean clinical manifestations. As culture is hazardous, time consuming and less sensitive, serological tests are preferred for the diagnosis. Agglutination tests like Rose Bengal Plate Test (RBPT), Serum Agglutination tests (SAT), 2-Mercaptoethanol test (2-ME) that are commonly employed for the diagnosis either lack sensitivity or specificity. Coombs test and Brucellacapt though are sensitive and specific, workout costly. Therefore, modified coagglutination test was developed and its diagnostic efficacy was evaluated. Aims and Objectives: To develop modified coagglutination test for the diagnosis of human brucellosis and compare it with Coombs test. Materials and Methods: Serum samples collected from 191 brucellosis patients and 100 controls were subjected to RBPT, SAT, 2-ME, Coombs test and modified coagglutination test (MCOAG). Blood culture was performed by Castaneda's method in all the patients. Results: Significant difference in the positivity rate was seen between MCOAG and 2-ME. The results of MCOAG were comparable with Coombs test. Conclusions: Modified coagglutination test is a better option to Coombs test for the serodiagnosis of brucellosis in resource constrained countries as it is sensitive, specific & cost effective.